查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088723

合成生物學市場：全球市場按產品類型、技術、分子類型、應用和最終用戶分類的預測——2026-2032年

Synthetic Biology Market by Product Type, Technology, Molecule Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，合成生物學市場將成長至 338.9 億美元，複合年成長率為 9.73%。

主要市場統計數據
基準年 2025 176.9億美元
預計年份：2026年 193.8億美元
預測年份 2032 338.9億美元
複合年成長率 (%) 9.73%

合成生物學市場簡介

合成生物學正從一個以研究主導的領域轉向一個工業平台，其應用範圍涵蓋醫療保健、農業、化學、材料、食品系統和環境等領域。 DNA合成、基因組編輯、高通量篩檢、自動化和雲端生物製造平台等技術的進步，使得各機構能夠更快、更準確、更可重複地設計生物系統。

合成生物學領域的變革性變化

合成生物學領域正透過生物學、工程學、計算科學和先進製造技術的整合而重新定義。生物鑄造廠正在規範「設計、建造、測試、學習」的循環流程，而自動化液體處理、體學分析、次世代定序和實驗室機器人技術則有助於提高處理能力和數據品質。

人工智慧的累積影響

人工智慧正透過蛋白質設計、代謝途徑工程、菌株最佳化、生物數據解讀和實驗設計改進，成為合成生物學的核心驅動力。人工智慧模型有助於減少篩選可用基因構建體、酵素、代謝途徑和候選治療藥物所需的實驗室迭代次數。

關鍵區域洞察：全球對合成生物學的需求

隨著中國、印度、日本、韓國、新加坡和澳洲不斷拓展基因組學、生物製造和生物經濟領域的項目，亞太地區正逐漸成為合成生物學活動的中心。中國正大力投資於定序、細胞療法研究、工業生物技術和生物製造基礎設施，而印度則透過政府主導的舉措計畫、疫苗生產、生物相似藥和農業生物技術來提升其生物技術能力。日本、韓國、新加坡和澳洲在精準醫療、發酵、先進材料、生物鑄造基礎設施和工業生物技術方面展現出強大的實力。

來自主要組織（東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約）的見解

隨著新加坡、馬來西亞、泰國、印尼、越南和菲律賓加大對生物醫學研究、精準醫療、食品科技和生物基製造領域的投資，東協的重要性日益凸顯。新加坡憑藉其協調的研究基礎設施、先進的生物製造能力、充足的公共資金支持以及強大的醫藥和生命科學生態系統，已成為該地區最強大的合成生物學中心。同時，泰國和馬來西亞正在加強與農業、發酵和可再生生物來源相關的生物經濟項目。

主要國家的發展趨勢：合成生物學的關鍵市場

美國正透過創業投資資金、先進療法、雲端實驗室、基因組學和生物鑄造基礎設施引領合成生物學的商業化。同時，加拿大在基因組學、疫苗、精準醫療和永續生物製程擁有優勢。墨西哥正在生物製造、醫療設備和農業生物技術領域創造機遇，而巴西則在生質燃料、甘蔗生物技術、熱帶農業和生物基工業原料領域確立了強大的地位。

為行業領導者提供的實用建議

產業領導者應優先考慮平台策略而非單一資產開發。整合人工智慧設計工具、自動化技術、高品質生物資料集、實驗室資訊系統以及可擴展的發酵和細胞處理能力的企業，將更有利於縮短開發週期、提高可重複性並促進技術轉移。

調查方法

本執行摘要基於二手研究，參考了公開的科學、監管和機構資源，包括政府生物經濟戰略、基因測序成本數據、法規核准、同行評審的生物技術文獻、專利和政策出版物、臨床和農業生物技術的最新進展以及公開的行業資訊來源。分析重點在於合成生物學、基因組工程、人工智慧驅動的藥物發現、生物製造、生物安全和區域創新體係等領域的檢驗趨勢。

結論：策略展望

合成生物學正成為生物技術主導成長下一階段的基礎技術。其價值在於能夠設計生物系統以實現特定目標，從先進的療法、診斷方法、疫苗和生技藥品，到永續化學品、食品配料、農業材料、生物感測器和與氣候變遷相關的材料。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 合成生物學市場：依產品類型分類

  • 酵素
    • DNA修飾酶
      • 限制性內切酶
      • 聚合酵素
      • 紗布
    • RNA修飾酶
      • 逆轉錄酶
      • RNA聚合酵素
    • 蛋白質工程酶
      • 蛋白酶
      • Chaperone
  • 寡核苷酸
  • 遺傳物質
  • 試劑盒和試劑
    • 克隆試劑盒
    • PCR試劑盒
    • 基因組編輯試劑盒
  • 軟體
    • 設計軟體
    • 模擬軟體
    • 分析軟體
  • 服務
    • 基因合成服務
    • DNA組裝服務
    • 蛋白質表現服務

第8章 合成生物學市場：依技術分類

  • 基因組編輯
    • CRISPR-Cas系統
    • TALENs
  • DNA合成
    • 化學合成
    • 酵素合成
  • 基因組裝
  • 代謝工程
  • Synthetic Genomics
  • 無細胞系統

第9章 合成生物學市場：依分子類型分類

  • 基於DNA的系統
  • 基於RNA的系統
  • 基於蛋白質的系統
  • 代謝途徑系統

第10章 合成生物學市場：依應用領域分類

  • 農業
    • 基因改造作物
    • 合成肥料
  • 環境
    • 生物修復
    • 碳回收
    • 廢棄物處理
  • 產業
    • 生物催化劑
    • 生質燃料
    • 生質塑膠和生物聚合物
    • 特種化學品
  • 生命科學
    • 藥物發現
    • 基因治療
    • 個人化醫療
    • 疫苗研發

第11章 合成生物學市場：依最終用戶分類

  • 學術研究機構
  • 農業和食品公司
  • 受託研究機構
  • 製藥和生物技術公司

第12章 合成生物學市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 合成生物學市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 合成生物學市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Arzeda
  • Batavia Biosciences BV
  • Beam Therapeutics
  • BGI Genomics Co., Ltd.
  • Codexis, Inc.
  • Conagen, Inc.
  • Creative Enzymes
  • Danaher Corporation
  • DNA TwoPointO Inc.
  • Editas Medicine, Inc.
  • Eurofins Scientific SE
  • GenScript Biotech Corporation
  • Ginkgo Bioworks, Inc.
  • Illumina, Inc.
  • Merck KGaA
  • New England Biolabs GmbH
  • Novozymes A/S
  • Precigen, Inc.
  • QIAGEN NV
  • Sangamo Therapeutics
  • Scarab Genomics, LLC
  • Synlogic
  • Synthego Corporation
  • TeselaGen Service
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
Product Code: MRR-B9334AD6BE33

The Synthetic Biology Market is projected to grow by USD 33.89 billion at a CAGR of 9.73% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 17.69 billion
Estimated Year [2026] USD 19.38 billion
Forecast Year [2032] USD 33.89 billion
CAGR (%) 9.73%

Synthetic Biology Market Introduction

Synthetic biology is moving from a research-driven discipline into an industrial platform for healthcare, agriculture, chemicals, materials, food systems, and environmental applications. Advances in DNA synthesis, genome editing, high-throughput screening, automation, and cloud-enabled biofoundries are enabling organizations to design biological systems with greater speed, precision, and reproducibility.

The sector is supported by measurable technology progress. The U.S. National Human Genome Research Institute has documented a steep decline in genome sequencing costs from approximately USD 100 million per genome in 2001 to near the USD 1,000 level in recent years. This cost compression, combined with CRISPR-based editing, mRNA platforms, and AI-assisted biological design, is expanding the commercial feasibility of engineered cells, enzymes, microbes, biosensors, and nucleic acid-based products.

Transformative Shifts in the Synthetic Biology Landscape

The synthetic biology landscape is being reshaped by the convergence of biology, engineering, computation, and advanced manufacturing. Biofoundries are standardizing the design-build-test-learn cycle, while automated liquid handling, omics analytics, next-generation sequencing, and laboratory robotics are improving throughput and data quality.

Commercial demand is shifting from isolated proof-of-concept projects toward scalable platforms. Pharmaceutical developers are using synthetic biology for cell and gene therapies, mRNA technologies, biologics optimization, and programmable medicines. Industrial biotechnology is deploying engineered microbes to produce specialty chemicals, enzymes, biomaterials, and alternative proteins, while agricultural applications focus on biological inputs, nitrogen-use efficiency, crop resilience, and reduced dependence on synthetic chemical inputs.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a core accelerator for synthetic biology by improving protein design, pathway engineering, strain optimization, biological data interpretation, and experimental planning. AI models help reduce the number of wet-lab iterations required to identify viable genetic constructs, enzymes, metabolic pathways, and therapeutic candidates.

The impact is cumulative because each experimental cycle generates structured biological data that can improve future model performance. AI-enabled protein structure prediction, generative sequence design, automated literature mining, and robotic experimentation are strengthening the connection between computational prediction and biological validation, supporting faster product development in therapeutics, enzymes, diagnostics, bio-based chemicals, sustainable materials, and precision agriculture.

Key Regional Insights: Global Synthetic Biology Demand

Asia-Pacific is becoming a high-activity synthetic biology region as China, India, Japan, South Korea, Singapore, and Australia expand genomics, biomanufacturing, and bioeconomy programs. China has invested heavily in sequencing, cell therapy research, industrial biotechnology, and biomanufacturing infrastructure, while India is building biotechnology capacity through government-backed bioeconomy initiatives, vaccine production, biosimilars, and agricultural biotechnology. Japan, South Korea, Singapore, and Australia contribute strong capabilities in precision medicine, fermentation, advanced materials, biofoundry infrastructure, and industrial biotechnology.

North America remains a global leader, driven by the United States and Canada. The United States benefits from deep venture capital, NIH and NSF-funded research, advanced therapy regulatory pathways, academic translation, and federal bioeconomy policy support, while Canada contributes strengths in genomics, vaccines, precision medicine, and sustainable biomanufacturing. Europe is anchored by the European Union, Germany, France, the United Kingdom, Italy, and Spain, with strong academic translation, industrial biotechnology clusters, and sustainability-oriented regulation. Latin America, led by Brazil and Mexico, is advancing bio-based agriculture, biofuels, and industrial fermentation, while the Middle East is increasing biotechnology investment through food security, healthcare modernization, and GCC-led diversification strategies. Africa is emerging through genomics initiatives, infectious disease surveillance, agricultural biotechnology, and capacity-building programs that support local bioeconomy development.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is gaining relevance as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines invest in biomedical research, precision health, food technology, and bio-based manufacturing. Singapore is the region's strongest synthetic biology hub due to coordinated research infrastructure, advanced biomanufacturing capability, supportive public funding, and a strong pharmaceutical and life sciences ecosystem, while Thailand and Malaysia are strengthening bioeconomy programs linked to agriculture, fermentation, and renewable biological feedstocks.

The GCC is using biotechnology to support economic diversification, healthcare security, and food resilience, with Saudi Arabia, the United Arab Emirates, and Qatar funding life sciences ecosystems, genomics programs, and controlled-environment agriculture. The European Union emphasizes safe, sustainable, and regulated biotechnology through research funding, biosafety governance, circular bioeconomy priorities, and programs such as Horizon Europe. BRICS economies bring scale in population health, agriculture, manufacturing, and feedstock availability, while G7 countries dominate advanced R&D, regulatory capacity, intellectual property development, and commercialization pathways. NATO members are also increasing attention to biosecurity, supply-chain resilience, dual-use governance, and the protection of critical biotechnology infrastructure.

Key Country Insights: Leading Synthetic Biology Markets

The United States leads synthetic biology commercialization through venture funding, advanced therapeutics, cloud labs, genome engineering, and biofoundry infrastructure, while Canada contributes strengths in genomics, vaccines, precision medicine, and sustainable bioprocessing. Mexico is building opportunity in biomanufacturing, medical devices, and agricultural biotechnology, and Brazil has a strong position in biofuels, sugarcane-based biotechnology, tropical agriculture, and bio-based industrial inputs.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine world-class research with industrial biotechnology demand, advanced manufacturing, clinical translation, and sustainability-driven policy support, while Russia maintains capabilities in life sciences, agriculture, vaccine research, and biosecurity-related research. China is scaling genomics, cell therapy, fermentation, and biomanufacturing; India is expanding vaccines, biosimilars, diagnostics, and bio-based agriculture; Japan and South Korea are strong in precision medicine, biologics, automation, and industrial fermentation; and Australia is advancing synthetic biology for health, agriculture, mining, environmental resilience, and biosecurity preparedness.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platform strategies rather than single-asset development. Organizations that integrate AI design tools, automation, high-quality biological datasets, laboratory information systems, and scalable fermentation or cell-processing capacity are better positioned to reduce development timelines, improve reproducibility, and strengthen technology transfer.

Executives should also strengthen regulatory engagement, biosafety systems, biosecurity controls, and intellectual property strategy early in the development cycle. Partnerships with universities, public biofoundries, contract development and manufacturing organizations, and cloud-lab providers can accelerate validation. Leaders should map feedstock availability, supply-chain risks, energy requirements, workforce capabilities, and regional incentives before scaling commercial biomanufacturing assets.

Research Methodology

This executive summary is based on secondary research from public scientific, regulatory, and institutional sources, including government bioeconomy strategies, genome sequencing cost data, regulatory approvals, peer-reviewed biotechnology literature, patent and policy publications, clinical and agricultural biotechnology updates, and publicly available industry disclosures. The analysis emphasizes verifiable trends across synthetic biology, genome engineering, AI-enabled discovery, biomanufacturing, biosecurity, and regional innovation systems.

Insights were synthesized using a triangulation approach that compares technology adoption, policy direction, funding priorities, regulatory developments, scientific publication trends, infrastructure maturity, and commercial use cases. Geographic analysis considers research infrastructure, manufacturing capability, healthcare demand, agricultural priorities, feedstock access, workforce readiness, and biosecurity governance to identify practical opportunities and constraints across major markets.

Conclusion: Strategic Outlook

Synthetic biology is becoming a foundational technology for the next phase of biotechnology-led growth. Its value lies in the ability to engineer biological systems for targeted outcomes, from advanced therapies, diagnostics, vaccines, and biologics to sustainable chemicals, food ingredients, agricultural inputs, biosensors, and climate-relevant materials.

The strongest opportunities will emerge where AI, automation, regulatory readiness, biosafety governance, and scalable biomanufacturing converge. Organizations that invest in trusted data, responsible innovation, resilient supply chains, and regional partnerships will be best positioned to capture long-term value in the global synthetic biology market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Synthetic Biology Market, by Product Type

  • 7.1. Enzymes
    • 7.1.1. DNA Modifying Enzymes
      • 7.1.1.1. Restriction Enzymes
      • 7.1.1.2. Polymerases
      • 7.1.1.3. Ligases
    • 7.1.2. RNA Modifying Enzymes
      • 7.1.2.1. Reverse Transcriptases
      • 7.1.2.2. RNA Polymerases
    • 7.1.3. Protein Engineering Enzymes
      • 7.1.3.1. Proteases
      • 7.1.3.2. Chaperones
  • 7.2. Oligonucleotides
  • 7.3. Genetic Material
  • 7.4. Kits & Reagents
    • 7.4.1. Cloning Kits
    • 7.4.2. PCR Kits
    • 7.4.3. Genome Editing Kits
  • 7.5. Software
    • 7.5.1. Design Software
    • 7.5.2. Simulation Software
    • 7.5.3. Analysis Software
  • 7.6. Services
    • 7.6.1. Gene Synthesis Services
    • 7.6.2. DNA Assembly Services
    • 7.6.3. Protein Expression Services

8. Synthetic Biology Market, by Technology

  • 8.1. Genome Editing
    • 8.1.1. CRISPR Cas Systems
    • 8.1.2. TALENs
  • 8.2. DNA Synthesis
    • 8.2.1. Chemical Synthesis
    • 8.2.2. Enzymatic Synthesis
  • 8.3. Gene Assembly
  • 8.4. Metabolic Engineering
  • 8.5. Synthetic Genomics
  • 8.6. Cell Free Systems

9. Synthetic Biology Market, by Molecule Type

  • 9.1. DNA Based Systems
  • 9.2. RNA Based Systems
  • 9.3. Protein Based Systems
  • 9.4. Metabolic Pathway Systems

10. Synthetic Biology Market, by Application

  • 10.1. Agriculture
    • 10.1.1. Genetically Modified Crops
    • 10.1.2. Synthetic Fertilizers
  • 10.2. Environmental
    • 10.2.1. Bioremediation
    • 10.2.2. Carbon Capture
    • 10.2.3. Waste Treatment
  • 10.3. Industrial
    • 10.3.1. Biocatalysts
    • 10.3.2. Biofuels
    • 10.3.3. Bioplastics & Biopolymers
    • 10.3.4. Specialty Chemicals
  • 10.4. Life Sciences
    • 10.4.1. Drug Discovery
    • 10.4.2. Gene Therapy
    • 10.4.3. Personalized Medicine
    • 10.4.4. Vaccine Development

11. Synthetic Biology Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Agriculture & Food Companies
  • 11.3. Contract Research Organizations
  • 11.4. Pharmaceutical & Biotechnology Companies

12. Synthetic Biology Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Synthetic Biology Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Synthetic Biology Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. Amyris, Inc.
  • 16.3. Arzeda
  • 16.4. Batavia Biosciences B.V.
  • 16.5. Beam Therapeutics
  • 16.6. BGI Genomics Co., Ltd.
  • 16.7. Codexis, Inc.
  • 16.8. Conagen, Inc.
  • 16.9. Creative Enzymes
  • 16.10. Danaher Corporation
  • 16.11. DNA TwoPointO Inc.
  • 16.12. Editas Medicine, Inc.
  • 16.13. Eurofins Scientific SE
  • 16.14. GenScript Biotech Corporation
  • 16.15. Ginkgo Bioworks, Inc.
  • 16.16. Illumina, Inc.
  • 16.17. Merck KGaA
  • 16.18. New England Biolabs GmbH
  • 16.19. Novozymes A/S
  • 16.20. Precigen, Inc.
  • 16.21. QIAGEN N.V.
  • 16.22. Sangamo Therapeutics
  • 16.23. Scarab Genomics, LLC
  • 16.24. Synlogic
  • 16.25. Synthego Corporation
  • 16.26. TeselaGen Service
  • 16.27. Thermo Fisher Scientific Inc.
  • 16.28. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SYNTHETIC BIOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL SYNTHETIC BIOLOGY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL SYNTHETIC BIOLOGY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL SYNTHETIC BIOLOGY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DNA MODIFYING ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DNA MODIFYING ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DNA MODIFYING ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RESTRICTION ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RESTRICTION ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RESTRICTION ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POLYMERASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POLYMERASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POLYMERASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIGASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIGASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIGASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RNA MODIFYING ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RNA MODIFYING ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RNA MODIFYING ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RNA POLYMERASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RNA POLYMERASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RNA POLYMERASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROTEIN ENGINEERING ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PROTEIN ENGINEERING ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PROTEIN ENGINEERING ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PROTEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PROTEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PROTEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CHAPERONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CHAPERONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CHAPERONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GENETIC MATERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GENETIC MATERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GENETIC MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL KITS & REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL KITS & REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CLONING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CLONING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CLONING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PCR KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PCR KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GENOME EDITING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GENOME EDITING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GENOME EDITING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DESIGN SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DESIGN SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SIMULATION SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SIMULATION SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SIMULATION SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GENE SYNTHESIS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GENE SYNTHESIS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GENE SYNTHESIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DNA ASSEMBLY SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DNA ASSEMBLY SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DNA ASSEMBLY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PROTEIN EXPRESSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PROTEIN EXPRESSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PROTEIN EXPRESSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GENOME EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CRISPR CAS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CRISPR CAS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CRISPR CAS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TALENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TALENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TALENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DNA SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DNA SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GENE ASSEMBLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GENE ASSEMBLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GENE ASSEMBLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL METABOLIC ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL METABOLIC ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL METABOLIC ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SYNTHETIC GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SYNTHETIC GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SYNTHETIC GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CELL FREE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CELL FREE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CELL FREE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DNA BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DNA BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DNA BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL RNA BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL RNA BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL RNA BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PROTEIN BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PROTEIN BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PROTEIN BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL METABOLIC PATHWAY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL METABOLIC PATHWAY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL METABOLIC PATHWAY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL AGRICULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL AGRICULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AGRICULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL GENETICALLY MODIFIED CROPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL GENETICALLY MODIFIED CROPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL GENETICALLY MODIFIED CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SYNTHETIC FERTILIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SYNTHETIC FERTILIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SYNTHETIC FERTILIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ENVIRONMENTAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ENVIRONMENTAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ENVIRONMENTAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOREMEDIATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BIOREMEDIATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOREMEDIATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CARBON CAPTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CARBON CAPTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CARBON CAPTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL WASTE TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL WASTE TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL WASTE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL INDUSTRIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL INDUSTRIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL INDUSTRIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOCATALYSTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BIOCATALYSTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOCATALYSTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BIOFUELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOFUELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BIOFUELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOPLASTICS & BIOPOLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BIOPLASTICS & BIOPOLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOPLASTICS & BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL SPECIALTY CHEMICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL SPECIALTY CHEMICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL SPECIALTY CHEMICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL LIFE SCIENCES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL LIFE SCIENCES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL GENE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL AGRICULTURE & FOOD COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL AGRICULTURE & FOOD COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL AGRICULTURE & FOOD COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 313. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 314. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 315. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 318. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2018-2032 (USD MILLION)
  • TABLE 319. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 320. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2032 (USD MILLION)
  • TABLE 321. ASEAN SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. GCC SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 325. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 326. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 327. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 328. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 329. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 330. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 331. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 332. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 333. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 334. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 336. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 337. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2018-2032 (USD MILLION)
  • TABLE 338. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 339. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2032 (USD MILLION)
  • TABLE 340. GCC SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 341. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 342. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 344. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 345. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 346. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 347. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 348. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 349. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 350. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 351. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 352. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 353. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 354. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 355. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 356. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2018-2032 (USD MILLION)
  • TABLE 357. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 358. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2032 (USD MILLION)
  • TABLE 359. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 360. BRICS SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 361. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 362. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 363. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 364. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 365. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 366. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 367. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 368. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 369. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 370. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2018-2032 (USD MILLION)
  • TABLE 371. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 372. BRICS